“…evaluating palbociclib (CDK4/6) treatment outcome …”
https://www.biospace.com/article/rel...cer-treatment/
https://clincancerres.aacrjournals.o.../2131.abstract https://www.nature.com/articles/s41598-020-61416-1 I need to be more rigorous in monitoring/reading research, these articles were published in Jannuary/2020. I believe they are filing for FDA approval of Divitum. Nguyen |
All times are GMT -7. The time now is 06:04 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021